arrow
J

Jennifer Logue

lancaster university
H指数:29
被引数:3,762

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Age as a moderator of neurocognitive performance in patients with large B-cell lymphoma treated with axicabtagene ciloleucel

年龄作为接受阿西替尼胞苷治疗的大B细胞淋巴瘤患者神经认知表现的调节变量

2026-09-080
OAAI
Fenofibrate and progression of retinopathy in adults with diabetes: the randomised placebo-controlled LENS trial

非诺贝特和糖尿病成人视网膜病变的进展:随机安慰剂对照的LENS试验

2026-05-010
PRE
Preclinical Evaluation and First-In-Human Phase 1 Trial of AZD0186, a Novel, Oral Small Molecule Glucagon-Like Peptide-1 Receptor Agonist

AZD0186的临床前评估与首次人体I期试验,AZD0186是一种新型口服小分子胰高血糖素样肽-1受体激动剂

2025-08-280
OAAI
Cost-effectiveness of fenofibrate versus standard care for reducing the progression of diabetic retinopathy: An economic evaluation based on data from the LENS trial

非诺贝特与标准护理在延缓糖尿病视网膜病变进展中的成本效益:一项基于LENS试验数据的经济学评估

2025-07-030
OAAI
The implications of defining obesity as a disease: a report from the Association for the Study of Obesity 2021 annual conference

将肥胖定义为疾病的含义: 肥胖研究协会2021年会的报告

2023-04-0117
OAAI
Clinical burden, risk factor impact and outcomes following myocardial infarction and stroke: A 25-year individual patient level linkage study
2021-08-0123
OAAI
Preschool Obesity Is Associated With an Increased Risk of Childhood Fracture: A Longitudinal Cohort Study of 466,997 Children and Up to 11 Years of Follow-up in Catalonia, Spain

学龄前肥胖与儿童骨折风险增加相关: 西班牙加泰罗尼亚466,997名儿童的纵向队列研究和长达11年的随访

2020-04-0724
OAAI
Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 diabetes (SCORE-IT): a patient and healthcare professional consensus on a core outcome set for type 2 diabetes
2019-12-2941
OAAI